According to a new report by Polaris Market Research, the global hemophilia A treatment market was valued at USD 12.03 billion in 2025 and is projected to reach USD 14.82 billion by 2034, expanding at a CAGR of 2.35% over the forecast period. Growth is underpinned by rising awareness of hemophilia, growing adoption of prophylactic treatment regimens, and accelerating gene therapy...